Citation Impact
Citing Papers
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
2010 Standout
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea.
1995
Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhoea
1999
Early Versus Delayed Antiretroviral Therapy and Cerebrospinal Fluid Fungal Clearance in Adults With HIV and Cryptococcal Meningitis
2013 StandoutNobel
HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques
1995
Clinical and Biological Evolution of HIV-1 Seroconverters in Abidjan, Côte d'Ivoire, 1997–2000
2002 StandoutNobel
Is tenofovir involved in hypophosphatemia and decrease of tubular phosphate reabsorption in HIV-positive adults?
2005
A Trial Comparing Nucleoside Monotherapy with Combination Therapy in HIV-Infected Adults with CD4 Cell Counts from 200 to 500 per Cubic Millimeter
1996
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
1999 Standout
Greater Tenofovir‐Associated Renal Function Decline with Protease Inhibitor–Based versus Nonnucleoside Reverse‐Transcriptase Inhibitor–Based Therapy
2007
Updated US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis
2013
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
1997 Standout
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
1997 Standout
Tuberculosis in Patients with Human Immunodeficiency Virus Infection
1999 Standout
SIVagm infection of its natural African green monkey host
1996
Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders
2011 Standout
Is HIV a Model of Accelerated or Accentuated Aging?
2013
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
1998 Standout
Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men
2003
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Antiretroviral Therapy Adherence, Virologic and Immunologic Outcomes in Adolescents Compared With Adults in Southern Africa
2009
Chronic hepatitis B: Update 2009 #
2009 Standout
Pathogenesis of HIV-associated cardiovascular complications
2001
The intestinal epithelial barrier: a therapeutic target?
2016 Standout
Renal function with use of a tenofovir-containing initial antiretroviral regimen
2009
HIV as the cause of AIDS
1996 StandoutNobel
Simian Immunodeficiency Viruses of African Green Monkeys
1994
The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years
2007
An Approach to Vaccines against Human Immunodeficiency Virus
1996 StandoutNobel
Antiretroviral Treatment for Adult HIV Infection in 2002
2002
Intestinal permeability: An overview
1995
HIV and Aging: Time for a New Paradigm
2010
Practice Guidelines for the Management of Cryptococcal Disease
2000 Standout
Geroscience: Linking Aging to Chronic Disease
2014 Standout
Do Protease Inhibitors Increase the Risk for Coronary Heart Disease in Patients With HIV-1 Infection?
2002
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
2003 Standout
Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial
2009
Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic Review
2013
Human Immunodeficiency Virus Infection and AIDS in a Person with Negative Serology
1997 StandoutNobel
The 3-year renal safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretroviral-naive patients
2008
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
2013 Standout
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors
1998 Standout
Indinavir impairs endothelial function in healthy HIV-negative men
2005
Antiretroviral Therapy in Adults
2000
Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HIV and Recommendations for Postexposure Prophylaxis
2005 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Impaired replication of protease inhibitor-resistant HIV-1 in human thymus
2001
Simian Immunodeficiency Virus SIVagm.sab Infection of Caribbean African Green Monkeys: a New Model for the Study of SIV Pathogenesis in Natural Hosts
2006 StandoutNobel
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
2003 Standout
HIV Population Dynamics in Vivo: Implications for Genetic Variation, Pathogenesis, and Therapy
1995 StandoutScience
Immunological studies of the basis for the apathogenicity of simian immunodeficiency virus from African green monkeys.
1990
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
2007 Standout
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T Cells
1995 StandoutScience
Frequent Substitution Polymorphisms in African Green Monkey CCR5 Cluster at Critical Sites for Infections by Simian Immunodeficiency Virus SIVagm, Implying Ancient Virus-Host Coevolution
2001 StandoutNobel
Interventions for enhancing medication adherence
2008 Standout
High Levels of Viral Replication during Primary Simian Immunodeficiency Virus SIVagm Infection Are Rapidly and Strongly Controlled in African Green Monkeys
2000 StandoutNobel
Forecasting the Future of Cardiovascular Disease in the United States
2011 Standout
An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication
2004 StandoutNobel
Coronary Heart Disease in HIV-Infected Individuals
2003
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1
2000
Pharmacological Basis for Concentration-Controlled Therapy with Zidovudine, Lamivudine, and Indinavir
2001
Pathogenesis of human immunodeficiency virus infection
1993
Interventions for enhancing medication adherence
2014 Standout
Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.
2006
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Tumor necrosis factor-alpha (TNFα) regulates the epithelial barrier in the human intestinal cell line HT-29/B6
1999
High Levels of Viral Replication Contrast with Only Transient Changes in CD4+and CD8+Cell Numbers during the Early Phase of Experimental Infection with Simian Immunodeficiency Virus SIVmnd-1 inMandrillus sphinx
2002 StandoutNobel
Canarypox Virus-Induced Maturation of Dendritic Cells Is Mediated by Apoptotic Cell Death and Tumor Necrosis Factor Alpha Secretion
2000 StandoutNobel
Structure of HIV-1 reverse transcriptase bound to an inhibitor active against mutant reverse transcriptases resistant to other nonnucleoside inhibitors
2004 StandoutNobel
Sertoli-Sertoli and Sertoli-Germ Cell Interactions and Their Significance in Germ Cell Movement in the Seminiferous Epithelium during Spermatogenesis
2004 Standout
Positive Regulation of CXCR4 Expression and Signaling by Interleukin-7 in CD4+Mature Thymocytes Correlates with Their Capacity To Favor Human Immunodeficiency X4 Virus Replication
2003 StandoutNobel
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Gag p27-Specific B- and T-Cell Responses in Simian Immunodeficiency Virus SIVagm-Infected African Green Monkeys
2008 StandoutNobel
Intracellular Metabolism and In Vitro Activity of Tenofovir against Hepatitis B Virus
2006
Simian Immunodeficiency Virus Replicates to High Levels in Sooty Mangabeys without Inducing Disease
1998 StandoutNobel
Works of S Staszewski being referenced
Intestinale Permeabilität bei Patienten mit erworbenem Immundefekt — Syndrom (AIDS)
1991
Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study
2005
A Randomized, Controlled Trial of Indinavir, Zidovudine, and Lamivudine in Adults with Advanced Human Immunodeficiency Virus Type 1 Infection and Prior Antiretroviral Therapy
1999
Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study.
2000
Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group
1996
Update on study 006--EFV + AZT + 3TC versus the current 'standard of care' IDV + AZT + 3TC.
1999
Demonstration of cross-reactive antibodies able to elicit lysis of both HIV-1- and HIV-2-infected cells.
1990